Klotho Neurosciences, Inc. (KLTO) Stock Analysis

Klotho Neurosciences, Inc. (KLTO) is a publicly traded company in the HEALTHCARE sector. It trades at $0.52, carries a market capitalization of $56.66M. This page summarizes the public market data, fundamentals, and frequently asked questions for KLTO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.52
• Market Cap: $56.66M
• EPS: $-0.30
• 52-Week High: $3.91
• 52-Week Low: $0.16

Market Sentiment

Klotho Neurosciences, Inc. currently has a Bullish sentiment score of 0.22.

About Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. is an innovative biopharmaceutical company based in Omaha, Nebraska, committed to developing transformative therapies for neurological and age-related disorders as well as specialty diagnostics. With a strong focus on research excellence and a vision to address significant unmet medical needs, Klotho is poised to revolutionize treatment paradigms within the neurology sector. The company's dedication to pioneering solutions underscores its role as a key player in the...

GNG Research Analysis

GNG Research scores Klotho Neurosciences, Inc. (KLTO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KLTO.

Frequently Asked Questions

Does KLTO pay dividends?

Klotho Neurosciences, Inc. (KLTO) does not currently pay a regular dividend.

What is KLTO's market cap?

Klotho Neurosciences, Inc. (KLTO) has a market capitalization of $56.66M with a current stock price of $0.52.